The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Atripla vs. Viramune + Truvada

Jun 8, 2007

Dr. Wohl, I asked you about Atripla vs. Reyataz + Norvir + Truvada as first-line treatment options, and I detected a slight preference for Atripla. Id like to pose the same question for Atripla vs. Viramune + Truvada. Aside from dosing differences, what are the pros and cons of these two options in terms of side effects, efficacy and resistance development? Without the troublesome CNS effects, it seems that Viramune might be preferable over Sustiva. Thanks!

Response from Dr. Wohl

I do think the convenience of Atripla is hard to beat. However, clearly the drug is not for everyone - no regimen is - and there are excellent alternatives. As far as Truvada + Viramune, this would not be a first choice. Viramune is not as potent as Sustiva (a component of Atripla) also the drug is not recommended for patients with higher CD4 cell counts due to increased risk of side effects.

But, for those who start on Atripla and do not tolerate the Sustiva, Truvada + Viramune is a reasonable alternative. I would not generally start with this combo given the alternatives.


Pap Smear for Male's
overseas patient

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint